Breast Anatomy and Physiology — MCQs
Mammography can be best used in?
All are true for oxytocin EXCEPT:
In which of the following situations is breast conservation surgery not indicated?
Which of the following is the most sensitive investigation for ductal carcinoma in situ (DCIS) of the breast?
A radiopaque density may be noticed in poisoning by which of the following agents?
In the condition shown below, rib notching is present in which of the following ribs? (AIIMS Nov 2015)
For normal mammography, what is the nominal focal size of the X-ray tube used?
What is the typical radiation dose delivered during mammography?
Which of the following is NOT an indicator of malignancy on mammography?
Which of the following is NOT an indication of malignancy on mammography?
Breast Anatomy and Physiology Indian Medical PG Practice Questions and MCQs
Question 1: Mammography can be best used in?
- A. Early breast carcinoma (Correct Answer)
- B. Mastitis
- C. Fibroadenoma
- D. Phylloides tumor
Explanation: ***Early breast carcinoma*** - **Mammography** is the gold standard for **early detection of breast carcinoma**, particularly for identifying **microcalcifications** and small masses before they are palpable. - It plays a crucial role in **screening asymptomatic women** to reduce breast cancer mortality. *Mastitis* - **Mastitis** is an **inflammatory condition** of the breast, often associated with infection, which is usually diagnosed clinically. - While mammography might show diffuse **increased density**, it is not the primary diagnostic tool and often has limited value due to inflammatory changes masking pathology. *Fibroadenoma* - **Fibroadenomas** are **benign breast tumors** common in younger women, typically appearing as well-circumscribed masses on mammography. - While mammography can detect them, their characterization often requires **ultrasound** and **biopsy** for definitive diagnosis, as differentiation from malignant lesions can be challenging. *Phylloides tumor* - A **Phylloides tumor** is a rare tumor that can be benign, borderline, or malignant, and it typically presents as a rapidly growing, palpable mass. - Mammography may show a well-defined mass, but **ultrasound** and **core needle biopsy** are essential for accurate diagnosis and distinction from fibroadenomas or malignancy.
Question 2: All are true for oxytocin EXCEPT:
- A. Causes ejection of milk
- B. Secreted by anterior pituitary (Correct Answer)
- C. Polypeptide
- D. Secreted in both sexes
Explanation: ***Secreted by anterior pituitary*** - Oxytocin is synthesized in the **hypothalamus** (specifically the paraventricular and supraoptic nuclei) and then transported down axons to the **posterior pituitary gland**, where it is stored and released. - The **anterior pituitary** produces and secretes hormones like growth hormone, prolactin, TSH, ACTH, FSH, and LH, but not oxytocin or vasopressin. *Causes ejection of milk* - Oxytocin acts on **myoepithelial cells** surrounding the alveoli of the mammary glands, causing them to contract and eject milk during lactation. - This is known as the **milk ejection reflex** or "let-down" reflex, which is stimulated by suckling. *Polypeptide* - Oxytocin is a **peptide hormone** composed of nine amino acids, making it a small polypeptide. - Its specific amino acid sequence is **Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2**, with a disulfide bond between the cysteine residues. *Secreted in both sexes* - While most recognized for its roles in childbirth and lactation in females, oxytocin is also produced and secreted in **males**. - In males, it is involved in various functions including **sperm transport**, sexual arousal, ejaculation, and social bonding behaviors.
Question 3: In which of the following situations is breast conservation surgery not indicated?
- A. SLE
- B. Large pendular breast
- C. Diffuse microcalcification
- D. All of the options (Correct Answer)
Explanation: ***All of the options*** - All listed scenarios—**large pendular breast**, **SLE**, and **diffuse microcalcification**—represent situations where breast conservation surgery is generally contraindicated or challenging. - Their presence often necessitates alternative treatment approaches, such as mastectomy, to achieve optimal oncologic and cosmetic outcomes. *Large pendular breast* - While not an absolute contraindication, a **very large or pendulous breast** can make it difficult to achieve a satisfactory cosmetic outcome after breast conservation surgery. - The disproportionate breast size post-lumpectomy may lead to significant **asymmetry**, requiring further reconstructive procedures. *SLE* - Patients with **Systemic Lupus Erythematosus (SLE)** are at an increased risk of complications from radiation therapy, a mandatory component of breast conservation surgery. - They tend to experience more severe and prolonged **acute and chronic skin reactions** to radiation, which can significantly impair healing and quality of life. *Diffuse microcalcification* - **Diffuse microcalcification** within the breast can indicate widespread in situ carcinoma (e.g., DCIS) or an invasive carcinoma with extensive intraductal component. - In such cases, achieving **clear surgical margins** with breast conservation surgery can be challenging and often leads to multiple re-excisions or an increased risk of local recurrence.
Question 4: Which of the following is the most sensitive investigation for ductal carcinoma in situ (DCIS) of the breast?
- A. PET Scan
- B. Ultrasound
- C. Mammography (Correct Answer)
- D. MRI
Explanation: ***Mammography*** - **Mammography** is the **gold standard** and **primary imaging modality** for detecting **ductal carcinoma in situ (DCIS)**, primarily because it excels at visualizing **microcalcifications**, which are the hallmark of DCIS. - Approximately **80-90% of DCIS cases** present as **microcalcifications** on mammograms, making it the most important screening and diagnostic tool. - Mammography has **high sensitivity (85-95%)** for detecting DCIS, especially calcified forms, and is widely available and cost-effective. *MRI* - While **MRI** has high sensitivity for invasive breast cancer and can detect non-calcified DCIS, it is **not the primary screening tool** for DCIS detection. - MRI is typically used for **staging known DCIS**, evaluating **extent of disease**, detecting **additional foci**, and screening **high-risk patients**. - However, MRI has lower specificity and higher false-positive rates compared to mammography, limiting its use as a primary diagnostic tool. *PET Scan* - **PET scans** are generally **not sensitive** for detecting **DCIS** because DCIS lesions typically have a **low metabolic rate** and do not avidly take up the **FDG tracer**. - PET scans are primarily used for detecting **invasive cancers** and assessing **metastatic disease**, not for non-invasive lesions like DCIS. *Ultrasound* - **Ultrasound** has **limited sensitivity** for detecting **DCIS** because DCIS often does not present as a palpable mass or a distinct sonographic abnormality. - While ultrasound can be useful for evaluating palpable masses or guiding biopsies, it frequently **misses microcalcifications** that are characteristic of DCIS. - Ultrasound is mainly used as a **complementary tool** to mammography, not as a primary diagnostic modality for DCIS.
Question 5: A radiopaque density may be noticed in poisoning by which of the following agents?
- A. Chloroquine
- B. Phenazopyridine
- C. Ethylene glycol
- D. Chloral hydrate (Correct Answer)
Explanation: ***Chloral hydrate*** - Due to its halogenated structure, **chloral hydrate** can be radio-opaque on X-rays, making it one of the "CHIPES" substances. - This property allows for radiological detection of its presence in the **gastrointestinal tract** following ingestion, particularly in large overdoses. *Chloroquine* - **Chloroquine** is not significantly radio-opaque and is generally not detectable on plain radiographs following overdose. - Clinical diagnosis of chloroquine poisoning relies on symptoms such as **hypotension**, **cardiac arrhythmias**, and **hypokalemia**, not radiological findings. *Phenazopyridine* - **Phenazopyridine** is a urinary analgesic that does not possess properties that render it radiographically detectable. - Its metabolism and excretion do not produce **radio-opaque metabolites** or complexes. *Ethylene glycol* - **Ethylene glycol** itself is not radio-opaque on plain X-rays, and its presence is typically diagnosed through laboratory tests like anion gap metabolic acidosis. - While it can lead to the formation of **calcium oxalate crystals** in the kidneys, these are typically microscopic and not visible as general radiopacities in the GI tract.
Question 6: In the condition shown below, rib notching is present in which of the following ribs? (AIIMS Nov 2015)
- A. 3rd to 9th ribs (Correct Answer)
- B. 1st to 9th ribs
- C. 11th and 12th ribs
- D. All ribs
Explanation: **3rd to 9th ribs** - The image provided depicts **coarctation of the aorta**, characterized by a narrowing of the aorta, typically distal to the origin of the left subclavian artery. - In coarctation of the aorta, collateral circulation develops through the **intercostal arteries** to bypass the constriction, leading to their enlargement and subsequent erosion of the inferior margins of the **3rd to 9th ribs**, a finding known as "rib notching." *1st to 9th ribs* - While rib notching affects upper ribs, it typically **spares the 1st and 2nd ribs** because the superior intercostal arteries (which supply these ribs) originate directly from the subclavian artery, often proximal to the coarctation, so they do not participate in collateral circulation as significantly. - The pattern of notching is usually more concentrated in the mid-thoracic region. *11th and 12th ribs* - Rib notching from coarctation of the aorta is rarely observed in the **floating ribs** (11th and 12th ribs). - These ribs have a different anatomical relationship with the pleura and typically do not bear the brunt of increased collateral flow from the intercostal arteries in the same way as the higher ribs. *All ribs* - Rib notching is a localized phenomenon reflecting increased blood flow through specific intercostal arteries involved in collateral circulation due to aortic coarctation. - Therefore, it does **not affect all ribs**, and its absence in certain ribs (like the 1st, 2nd, 11th, and 12th) helps differentiate this condition radiologically.
Question 7: For normal mammography, what is the nominal focal size of the X-ray tube used?
- A. 0.2-0.25 mm
- B. 0.3-0.35 mm (Correct Answer)
- C. 0.4-0.45 mm
- D. 0.45-0.50 mm
Explanation: In mammography, high spatial resolution is critical for detecting tiny structures like microcalcifications. The focal spot size directly influences **geometric blurring** (penumbra); a smaller focal spot results in a sharper image. ### 1. Why Option B is Correct For **routine (normal) mammography**, a nominal focal spot size of **0.3 mm** (typically ranging from 0.3 to 0.35 mm) is the standard. This size provides an optimal balance: it is small enough to ensure high detail for screening while being large enough to withstand the heat generated by the X-ray tube during standard exposures without damaging the anode. ### 2. Why Other Options are Incorrect * **Option A (0.2-0.25 mm):** This is too large for magnification but smaller than the standard for routine screening. * **Options C & D (0.4-0.5 mm):** These sizes are used in general radiography (e.g., Chest X-rays, where focal spots are often 0.6–1.2 mm). In mammography, such large spots would cause excessive geometric blurring, making it impossible to see fine architectural distortions. ### 3. High-Yield Clinical Pearls for NEET-PG * **Magnification Mammography:** When a specific area needs to be magnified, a much smaller focal spot of **0.1 mm** (range 0.1–0.15 mm) is used to compensate for the increased blurring caused by the air gap. * **Anode Material:** Usually **Molybdenum (Mo)** or Rhodium (Rh) is used to produce low-energy (soft) X-rays (25–30 kVp) for better soft-tissue contrast. * **Orientation:** The cathode is placed over the **base of the breast** (chest wall) and the anode over the **apex** (nipple) to utilize the "Heel Effect" for uniform density.
Question 8: What is the typical radiation dose delivered during mammography?
- A. 0.1 Gray/study
- B. 0.01 centiGray/study
- C. 0.1 centiGray/study (Correct Answer)
- D. 0.01 Gray/study
Explanation: ### Explanation **1. Why Option C is Correct:** The radiation dose in mammography is measured as the **Mean Glandular Dose (MGD)**, which represents the average dose to the radiosensitive glandular tissue of the breast. For a standard two-view screening mammogram (per breast), the typical dose is approximately **1 to 2 mGy (0.1 to 0.2 rad)**. Since **1 rad = 1 centiGray (cGy)**, a dose of 0.1 rad is equivalent to **0.1 cGy**. This level of radiation is considered very low and is roughly equivalent to the amount of natural background radiation a person receives over seven weeks. **2. Why Other Options are Incorrect:** * **Option A (0.1 Gray):** This is equivalent to 100 mGy. This dose is far too high for diagnostic imaging and would be closer to levels used in therapeutic radiation or causing deterministic effects. * **Option B (0.01 cGy):** This is 0.1 mGy, which is too low to produce a diagnostic quality image of dense breast tissue. * **Option D (0.01 Gray):** This is equivalent to 10 mGy (1 rad). While some complex interventional procedures might reach this level, it is significantly higher than the standard dose for a screening mammogram. **3. High-Yield Clinical Pearls for NEET-PG:** * **Target/Filter Material:** Mammography uses low-energy X-rays (typically **25–35 kVp**) to maximize soft tissue contrast. Common target/filter combinations are **Molybdenum/Molybdenum** or **Rhodium**. * **MQSA Requirement:** The Mammography Quality Standards Act (MQSA) mandates that the dose should not exceed **3 mGy (0.3 cGy)** per view with a grid. * **Screening Guidelines:** In India, the general recommendation is annual or biennial screening starting at age 40–50 years. * **Risk vs. Benefit:** The risk of radiation-induced breast cancer is negligible compared to the benefit of early detection of spontaneous breast cancer.
Question 9: Which of the following is NOT an indicator of malignancy on mammography?
- A. Nodular calcification (Correct Answer)
- B. Speckled margin
- C. Attenuated architecture
- D. Irregular mass
Explanation: **Explanation:** In mammography, distinguishing between benign and malignant lesions depends on analyzing mass morphology, margins, and calcification patterns. **1. Why "Nodular Calcification" is the correct answer:** Nodular (or "popcorn-like") calcifications are typically large, coarse, and well-defined. These are classic features of **benign** lesions, most commonly seen in involuting **fibroadenomas**. Malignant calcifications, by contrast, are usually pleomorphic (variable shapes), fine-linear, or branching (casting), representing necrosis within ducts (e.g., DCIS). **2. Analysis of Incorrect Options (Indicators of Malignancy):** * **Speckled (Spiculated) Margin:** This is the most specific mammographic sign of malignancy. It represents the desmoplastic reaction of the surrounding tissue as the tumor invades. * **Attenuated (Distorted) Architecture:** Architectural distortion occurs when the normal radial septa of the breast are pulled or straightened. In the absence of a history of trauma or surgery, this is highly suspicious for invasive breast cancer. * **Irregular Mass:** Malignant tumors grow haphazardly, leading to an irregular shape rather than a smooth, round, or oval appearance (which favors benignity). **Clinical Pearls for NEET-PG:** * **BI-RADS Classification:** Used for standardized reporting. BI-RADS 5 indicates >95% risk of malignancy. * **Most common benign calcification:** Popcorn-like (Fibroadenoma). * **Most common malignant calcification:** Fine pleomorphic or fine-linear branching. * **Skin Changes:** Skin thickening (>2mm) and nipple retraction are secondary signs of malignancy. * **Screening:** Mammography is the gold standard for screening, but Ultrasound is the investigation of choice for women <35 years due to dense breast tissue.
Question 10: Which of the following is NOT an indication of malignancy on mammography?
- A. Nodular calcification (Correct Answer)
- B. Speckled margin
- C. Attenuated architecture
- D. Irregular mass
Explanation: ### Explanation In mammography, the primary goal is to differentiate between benign and malignant features based on mass morphology, margins, and calcification patterns. **1. Why "Nodular Calcification" is the correct answer:** Nodular (or "popcorn-like") calcifications are typically large, coarse, and well-defined. These are classic features of **benign** lesions, most commonly seen in **involuting fibroadenomas**. Malignant calcifications, by contrast, are usually pleomorphic, fine-linear, or branching (casting type), representing necrotic debris within ducts (as seen in DCIS). **2. Analysis of Incorrect Options (Malignant Features):** * **Speckled (Spiculated) Margin:** This is the most specific mammographic sign of malignancy. It represents the infiltration of cancer cells into surrounding tissue and the subsequent desmoplastic reaction. * **Attenuated (Distorted) Architecture:** Architectural distortion refers to the pulling or tethering of normal breast parenchyma without a visible central mass. While it can occur in post-surgical scars, in a screening context, it is highly suspicious for invasive lobular or ductal carcinoma. * **Irregular Mass:** Malignant tumors grow haphazardly, leading to an irregular shape. Benign lesions are more likely to be round, oval, or circumscribed. **3. High-Yield Clinical Pearls for NEET-PG:** * **BI-RADS Classification:** Used for standardized reporting. BI-RADS 4 and 5 indicate high suspicion of malignancy. * **Most specific sign of malignancy:** Spiculated margins. * **Benign Calcifications:** Popcorn (Fibroadenoma), Eggshell/Rim (Oil cysts), and Teardrop (Milk of calcium). * **Malignant Calcifications:** Fine pleomorphic or fine-linear branching (BI-RADS 5). * **Initial Investigation:** Mammography is the gold standard for screening women >40 years; Ultrasound is preferred for women <30 years or during pregnancy/lactation.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free